Impact of autonomic dysfunction on inflammatory bowel disease

Journal of Clinical Gastroenterology

Volumn 44, Issue 4, 2010, Pages 272-279

  Ananthakrishnan, Ashwin N ^a   Issa, Mazen ^a   Barboi, Alexandru ^b   Jaradeh, Safwan ^b   Zadvornova, Yelena ^a   Skaros, Sue ^a   Johnson, Kathryn ^a   Otterson, Mary F ^b   Binion, David G ^c  

^a CLEMENT J ZABLOCKI VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b MEDICAL COLLEGE OF WISCONSIN   (United States)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Autonomic dysfunction; Crohn's disease; Functional bowel disorders; Health related quality of life; IBD; Inflammatory bowel disease; Ulcerative colitis

Indexed keywords

ADULT; ARTICLE; AUTONOMIC DYSFUNCTION; CASE CONTROL STUDY; CLINICAL ARTICLE; COMORBIDITY; CONTROLLED STUDY; DISEASE ACTIVITY; ENTERITIS; FEMALE; HEALTH CARE UTILIZATION; HUMAN; INTESTINE TRANSIT TIME; MALE; MENTAL DISEASE; PRIORITY JOURNAL; QUALITY OF LIFE; SCORING SYSTEM; SEX DIFFERENCE; WORK DISABILITY;

ADULT; AUTONOMIC NERVOUS SYSTEM DISEASES; CASE-CONTROL STUDIES; COLITIS, ULCERATIVE; CROHN DISEASE; DELIVERY OF HEALTH CARE; FEMALE; HUMANS; INFLAMMATORY BOWEL DISEASES; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; QUALITY OF LIFE; QUESTIONNAIRES; SEVERITY OF ILLNESS INDEX;

EID: 77949971633     PISSN: 01920790     EISSN: None     Source Type: Journal    
DOI: 10.1097/MCG.0b013e3181b2682a     Document Type: Article

References (37)

1. Barratt HS, Kalantzis C, Polymeros D, et al. Functional symptoms in inflammatory bowel disease and their potential influence in misclassification of clinical status. Aliment Pharmacol Ther. 2005;21:141-147.
2. Minderhoud IM, Oldenburg B, Wismeijer JA, et al. IBS-like symptoms in patients with inflammatory bowel disease in remission; relationships with quality of life and coping behavior. Dig Dis Sci. 2004;49:469-474.
3. Simren M, Axelsson J, Gillberg R, et al. Quality of life in inflammatory bowel disease in remission: the impact of IBS-like symptoms and associated psychological factors. Am J Gastroenterol. 2002;97:389-396.
4. Burgmann T, Clara I, Graff L, et al. The Manitoba Inflammatory Bowel Disease Cohort Study: prolonged symptoms before diagnosis-how much is irritable bowel syndrome? Clin Gastroenterol Hepatol. 2006;4:614-620.
5. Bayless TM, Harris ML. Inflammatory bowel disease and irritable bowel syndrome. Med Clin North Am. 1990;74:21-28.
6. Sandborn WJ, Colombel JF, Enns R, et al. Natalizumab induction and maintenance therapy for Crohn,s disease. N Engl J Med. 2005;353:1912-1925.
7. Schreiber S, Rutgeerts P, Fedorak RN, et al. A randomized, placebo-controlled trial of certolizumab pegol (CDP870) for treatment of Crohn,s disease. Gastroenterology. 2005;129: 807-818.
8. Lawal A, Barboi A, Krasnow A, et al. Rapid gastric emptying is more common than gastroparesis in patients with autonomic dysfunction. Am J Gastroenterol. 2007;102:618-623.
9. Vinik AI, Maser RE, Mitchell BD, et al. Diabetic autonomic neuropathy. Diabetes Care. 2003;26:1553-1579.
10. Stojanovich L, Milovanovich B, de Luka SR, et al. Cardiovascular autonomic dysfunction in systemic lupus, rheumatoid arthritis, primary Sjogren syndrome and other autoimmune diseases. Lupus. 2007;16:181-185.
11. Straub RH, Baerwald CG, Wahle M, et al. Autonomic dysfunction in rheumatic diseases. Rheum Dis Clin North Am. 2005;31:61-75, viii.
12. Hendrickse MT, Thuluvath PJ, Triger DR. Natural history of autonomic neuropathy in chronic liver disease. Lancet. 1992;339:1462-1464.
13. Hendrickse MT, Triger DR. Autonomic and peripheral neuropathy in primary biliary cirrhosis. J Hepatol. 1993;19: 401-407.
14. Newton JL, Hudson M, Tachtatzis P, et al. Population prevalence and symptom associations of autonomic dysfunction in primary biliary cirrhosis. Hepatology. 2007;45:1496-1505.
15. Chyun DA, Melkus GD, Katten DM, et al. The association of psychological factors, physical activity, neuropathy, and quality of life in type 2 diabetes. Biol Res Nurs. 2006;7:279-288.
16. Longobardi T, Bernstein CN. Health care resource utilization in inflammatory bowel disease. Clin Gastroenterol Hepatol. 2006;4:731-743.
17. Coruzzi P, Castiglioni P, Parati G, et al. Autonomic cardiovascular regulation in quiescent ulcerative colitis and Crohn,s disease. Eur J Clin Invest. 2007;37:964-970.
18. Ganguli SC, Kamath MV, Redmond K, et al. A comparison of autonomic function in patients with inflammatory bowel disease and in healthy controls. Neurogastroenterol Motil. 2007;19:961-967.
19. Lindgren S, Lilja B, Rosen I, et al. Disturbed autonomic nerve function in patients with Crohn,s disease. Scand J Gastroenterol. 1991;26:361-366.
20. Lindgren S, Stewenius J, Sjolund K, et al. Autonomic vagal nerve dysfunction in patients with ulcerative colitis. Scand J Gastroenterol. 1993;28:638-642.
21. Ohlsson B, Sundkvist G, Lindgren S. Subclinical sympathetic neuropathy appears early in the course of Crohn,s disease. BMC Gastroenterol. 2007;7:33.
22. Straub RH, Antoniou E, Zeuner M, et al. Association of autonomic nervous hyperreflexia and systemic inflammation in patients with Crohn,s disease and ulcerative colitis. J Neuroimmunol. 1997;80:149-157.
23. Taylor CT, Keely SJ. The autonomic nervous system and inflammatory bowel disease. Auton Neurosci. 2007;133:104-114.
24. Maule S, Pierangeli G, Cevoli S, et al. Sympathetic hyperactivity in patients with ulcerative colitis. Clin Auton Res. 2007; 17:217-220.
25. Ananthakrishnan AN, Weber LR, Knox JF, et al. Permanent work disability in Crohn,s disease. Am J Gastroenterol. 2008; 103:154-161.
26. Satsangi J, Silverberg MS, Vermeire S, et al. The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications. Gut. 2006;55:749-753.
27. Vermeire S, Van Assche G, Rutgeerts P. Laboratory markers in IBD: useful, magic, or unnecessary toys? Gut. 2006;55: 426-431.
28. Irvine EJ, Zhou Q, Thompson AK. The Short Inflammatory Bowel Disease Questionnaire: a quality of life instrument for community physicians managing inflammatory bowel disease. CCRPT Investigators. Canadian Crohn,s Relapse Prevention Trial. Am J Gastroenterol. 1996;91:1571-1578.
29. Jowett SL, Seal CJ, Barton JR, et al. The short inflammatory bowel disease questionnaire is reliable and responsive to clinically important change in ulcerative colitis. Am J Gastroenterol. 2001;96:2921-2928.
30. Harvey RF, Bradshaw JM. A simple index of Crohn,s-disease activity. Lancet. 1980;1:514.
31. Kozarek RA, Patterson DJ, Gelfand MD, et al. Methotrexate induces clinical and histologic remission in patients with refractory inflammatory bowel disease. Ann Intern Med. 1989; 110:353-356.
32. Low PA. Testing the autonomic nervous system. Semin Neurol. 2003;23:407-421.
33. Low PA. Composite autonomic scoring scale for laboratory quantification of generalized autonomic failure.Mayo Clin Proc. 1993;68:748-752.
34. Straub RH, Wiest R, Strauch UG, et al. The role of the sympathetic nervous system in intestinal inflammation. Gut. 2006;55:1640-1649.
35. Straub RH, Grum F, Strauch U, et al. Anti-inflammatory role of sympathetic nerves in chronic intestinal inflammation. Gut. 2008;57:911-921.
36. Kamphuis MH, Geerlings MI, Dekker JM, et al. Autonomic dysfunction: a link between depression and cardiovascular mortality? The FINE Study. Eur J Cardiovasc Prev Rehabil. 2007;14:796-802.
37. Pizzi C, Manzoli L, Mancini S, et al. Analysis of potential predictors of depression among coronary heart disease risk factors including heart rate variability, markers of inflammation, and endothelial function. Eur Heart J. 2008;29: 1110-1117.